Couvineau Pierre, de Almeida Hugo, Maigret Bernard, Llorens-Cortes Catherine, Iturrioz Xavier
Laboratory of central neuropeptides in the regulation of body fluid homeostasis and cardiovascular functions, INSERM U1050, Paris, France.
Center for Interdisciplinary Research in Biology (CIRB), Collège de France, Paris, France.
PLoS One. 2017 Sep 6;12(9):e0184237. doi: 10.1371/journal.pone.0184237. eCollection 2017.
Aminopeptidase A (APA) is a membrane-bound zinc metalloprotease cleaving, in the brain, the N-terminal aspartyl residue of angiotensin II to generate angiotensin III, which exerts a tonic stimulatory effect on the control of blood pressure in hypertensive animals. Using a refined APA structure derived from the human APA crystal structure, we docked the specific and selective APA inhibitor, EC33 in the presence of Ca2+. We report the presence in the S1 subsite of Arg-887 (Arg-878 in mouse APA), the guanidinium moiety of which established an interaction with the electronegative sulfonate group of EC33. Mutagenic replacement of Arg-878 with an alanine or a lysine residue decreased the affinity of the recombinant enzymes for the acidic substrate, α-L-glutamyl-β-naphthylamide, with a slight decrease in substrate hydrolysis velocity either with or without Ca2+. In the absence of Ca2+, the mutations modified the substrate specificity of APA for the acidic substrate, the mutated enzymes hydrolyzing more efficiently basic and neutral substrates, although the addition of Ca2+ partially restored the acidic substrate specificity. The analysis of the 3D models of the Arg-878 mutated APAs revealed a change in the volume of the S1 subsite, which may impair the binding and/or the optimal positioning of the substrate in the active site as well as its hydrolysis. These findings demonstrate the key role of Arg-878 together with Ca2 + in APA substrate specificity for N-terminal acidic amino acid residues by ensuring the optimal positioning of acidic substrates during catalysis.
氨肽酶A(APA)是一种膜结合锌金属蛋白酶,在大脑中可切割血管紧张素II的N端天冬氨酰残基生成血管紧张素III,血管紧张素III对高血压动物的血压控制具有持续性刺激作用。利用源自人APA晶体结构的精细APA结构,我们在存在Ca2+的情况下对接了特异性和选择性APA抑制剂EC33。我们报告在Arg-887(小鼠APA中的Arg-878)的S1亚位点存在该物质,其胍基部分与EC33的带负电磺酸根基团建立了相互作用。将Arg-878突变为丙氨酸或赖氨酸残基会降低重组酶对酸性底物α-L-谷氨酰-β-萘酰胺的亲和力,无论有无Ca2+,底物水解速度均略有下降。在没有Ca2+的情况下,这些突变改变了APA对酸性底物的底物特异性,突变酶能更有效地水解碱性和中性底物,不过添加Ca2+可部分恢复酸性底物特异性。对Arg-878突变的APA的三维模型分析显示,S1亚位点的体积发生了变化,这可能会损害底物在活性位点的结合和/或最佳定位及其水解。这些发现证明了Arg-878与Ca2+在APA对N端酸性氨基酸残基的底物特异性中起着关键作用,通过在催化过程中确保酸性底物的最佳定位来实现。